Access to antibiotics in the Nordic region, v. 02
(Please note that the agenda may be subject to changes)
Monday 25 November 2024
|
|
||
|
10:00 |
Welcome |
Petra Noreback Ministry of Social Affairs |
|
10:10 |
Welcome |
Joakim Brandberg Swedish Medical Products Agency |
|
10.20 |
Welcome |
Malin Grape AMR Ambassador, Sweden |
|
10.30 |
Ensuring global access to effective antibiotics Global access to antibiotics to counteract development of AMR. |
Otto Cars Professor emeritus, Infectionus diseases, Uppsala University Founder, ReAct Action on Antibiotic Resistance |
|
10.45 |
One Health An integrated, unifying approach to balance and optimize the health of people, animals, and the environment. |
Susanna Sternberg Lewerin Swedish Veterinary Agency |
|
11.00 |
Survey of the antibiotic market in the Nordic region An overview of all formulations, strengths, and packages of registered antibiotics for human use in the Nordic region. |
Anders Ternhag Swedish Public Health Authority |
|
11.15 |
Supply chain transparency Supply chain transparency and improved information sharing about supply and needs are factors that could improve access to antibiotics for both human and animals. |
Enrico Baraldi PLATINEA |
|
11.30 |
Poster pitch |
|
|
12.00 |
LUNCH |
|
|
13.00 |
Mapping of production capacity Mapping of production capacity- a Swedish Government Assignment. |
Ulrika Espefält Westin Swedish Medical Products Agency |
|
13.15 |
Withdraw or keep antibiotics on the Nordic market? Reasons behind strategic decisions from the industry whether to keep or withdraw antibiotics from the Nordic market. |
Adam Estrup ViNordic |
|
13.30 |
Shortages - industry perspective Presentation from the industry perspective of shortages and access of antibiotics. |
Bengt Mattson LIF |
|
13:45 |
Available antibiotics for veterinary use An overview of formulations, strengths, and packages of registered antibiotics for veterinary use in the Nordic region. |
Swedish Medical Products Agency |
|
14.00 |
Treatment recommendations - Healthcare perspective Impact of updated treatment recommendations from a healthcare perspective as well as an overview of the ongoing initiatives and collaboration. |
Thomas Tängdén STRAMA |
|
14.15 |
Treatment recommendations - Veterinary perspective Importance of updated treatment recommendations for veterinaries and the consequence of shortages. |
To be confirmed |
|
14.30 |
Access to antibiotics in Iceland
|
Olof Thorhallsdottir Icelandic Medicines Agency |
|
14.45 |
Access to antibiotics in Finland |
To be confirmed |
|
15.00 |
COFFEE AND PHOTO |
|
|
15.30 |
Access to antiobbiotics in Greenland/Denmark
|
To be confirmed |
|
15.45 |
Managing AMR in the environment while maintaining access to antibiotics Examples related to antibiotic pollution from both manufacturing and use. |
Joakim Larsson Gothenburg University |
|
16.00 |
Environmental premium within the Swedish pharmaceutical benefits system Ongoing government assignment to incentivise environmental responsibility in production of pharmaceuticals. |
Krister Halldin Swedish Medical Products Agency |
|
16.15 |
AMR in legislations Legislation from different sectors counteract AMR. |
Åsa Kumlin Howell Swedish Medical Products Agency |
|
16.30 |
Nordic common packaging Possibility to register Nordic packaging to reduced regulatory administration for antibiotics. Relevant for both human and veterinary antibiotics. |
To be confirmed |
|
16.45 |
MRP- Fast track for antibiotics Possibility to use Mutual Recognition Process (MRP) when registering antibiotics in the Nordic region. Relevant for both human and veterinary antibiotics. |
To be confirmed |
|
17.00 |
Closure |
|
Access to antibiotics in the Nordic region
Tuesday 26 November 2024
|
|
||
|
09.00 |
JAMRAI-2 Ongoing European project with the objective to increase access to antibiotics for human and animals. |
Christine Årdal Norwegian Institute of Public Health |
|
09.15 |
Nordic reimbursement model Outcome of reimbursement model and ongoing initiative to implement the model in the Nordic region to ensure future access to antibiotics. |
Jenny Hellman Swedish Public Health Authority |
|
09.30 |
Nordic procurement initiative with environment incentives for the industry Ongoing Nordic procurement initiative with environmental incentives for antibiotics. |
Gudrun Gudnadottir Sykehusinnkjøp HF |
|
09.45 |
Funding research and development Comparative study on pull incentives for antibiotcs R&D |
Carl Björvang The dental and pharmaceutical benefits agency |
|
10:00 |
Nordic AMR initiatives, human, animal, and environment sector Initiatives in the Nordic region within human, veterinary and environment sector. |
Marmar Nekoro Swedish Medical Products Agency |
|
10:15 |
Challenges with clinical trials when developing new antibiotics |
Gunilla Andrew Nielsen Swedish Medical Products Agency |
|
10:30 |
Antibiotics in pipeline |
Anders Karlén Uppsala university |
|
10.40 |
COFFEE |
|
|
11.00 |
Workshops |
|
|
12.30 |
LUNCH |
|
|
13.30 |
Workshops |
|
|
15.00 |
COFFEE |
|
|
15.30 |
Summary/Next step |
Swedish Medical Products Agency |
|
16.00 |
Closure |
|
|
|
|
|